Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation

Nico Gagelmann, Anita Badbaran, Rashit Bogdanov, PhD, Olivier Nibourel, Friedrich Stoelzel, MD, Christina Rautenberg, MD, Heiko Becker, MD, Aleksandar Radujkovic, MD, Michael Koldehoff, Prof, MD PhD, Maximilian Christopeit, PhD, Peter Dreger, Jürgen Finke, MD, Guido Kobbe, MD, Uwe Platzbecker, Marie Robin, MD, Dietrich W. Beelen, Nicolaus Kroeger, MD

Blood (2019) 134 (Supplement_1): 1713.

https://doi.org/10.1182/blood-2019-121969

Published: 2019

Journal Articles

Easix for Prediction of Survival in Myelodysplastic Syndromes

Almuth Maria Anni Merz, MD, Ulrich Germing, MD, Guido Kobbe, MD, Jennifer Kaivers, MD, Anna Jauch, Aleksandar Radujkovic, MD, Manuela Hummel, Axel Benner, Maximilian Merz, Peter Dreger, Thomas Luft, MD PhD

Blood (2019) 134 (Supplement_1): 1722.

https://doi.org/10.1182/blood-2019-122622

Published: 2019

Journal Articles

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Thomas Luft, MD PhD, Hao Dai, Aleksandar Radujkovic, MD, David Schult, Joshua Majer-Lauterbach, Olga Blau, MD PhD, Lars Bullinger, Sihe Jiang, Carsten Müller-Tidow, MD, Peter Dreger, Olaf Penack, MD

Blood (2019) 134 (Supplement_1): 4487.

https://doi.org/10.1182/blood-2019-124284

Published: 2019

Journal Articles

Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 4581.

https://doi.org/10.1182/blood-2019-125077

Published: 2019

Journal Articles

High Pre-Transplant Free Interleukin-18 Is Associated with Poor Hematopoietic Recovery after Allogeneic Stem Cell Transplantation

Lambros Kordelas, MD, Aleksandar Radujkovic, MD, Hao Dai, Rashit Bogdanov, PhD, Dietrich W. Beelen, Carsten Müller-Tidow, MD, Peter Dreger, Thomas Luft, MD PhD

Blood (2019) 134 (Supplement_1): 4507.

https://doi.org/10.1182/blood-2019-124278

Published: 2019

Journal Articles

Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT

Blood (2019) 134 (Supplement_1): 3335.

https://doi.org/10.1182/blood-2019-121820

Published: 2019

Journal Articles

The CXCL9 Polymorphism rs884304 Associates with Early CXCL9 Reconstitution and with Severe Chronic Graft-Versus-Host Disease (cGVHD) in Human Allograft Recipients

Hao Dai, Sivaramakrishna P. Rachakonda, PhD, Olaf Penack, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Rajiv Kumar, PhD, Peter Dreger, Thomas Luft, MD PhD

Blood (2019) 134 (Supplement_1): 873.

https://doi.org/10.1182/blood-2019-124742

Published: 2019

Journal Articles

Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands

Hao Dai, Sivaramakrishna P. Rachakonda, PhD, Olaf Penack, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Olga Blau, MD PhD, Igor-Wolfgang Blau, MD PhD, Rajiv Kumar, PhD, Peter Dreger, Thomas Luft, MD PhD

Blood (2018) 132 (Supplement 1): 357.

https://doi.org/10.1182/blood-2018-99-113820

Published: 2018

Journal Articles

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Mark-Alexander Schwarzbich, MD, Hao Dai, Lambros Kordelas, MD, Dietrich W. Beelen, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2018) 132 (Supplement 1): 3419.

https://doi.org/10.1182/blood-2018-99-112807

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors — a Retrospective Study By the EBMT Chronic Malignancies Working Party

Blood (2018) 132 (Supplement 1): 3465.

https://doi.org/10.1182/blood-2018-99-114592

Published: 2018

Journal Articles

Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Blood (2017) 130 (Supplement 1): 3307.

https://doi.org/10.1182/blood.V130.Suppl_1.3307.3307

Published: 2017

Journal Articles

Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins

Thomas Luft, MD PhD, Sivaramakrishna P. Rachakonda, PhD, Hao Dai, Olaf Penack, MD, Olga Blau, Igor Wolfgang Blau, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, Peter Dreger, MD, Rajive Kumar, PhD

Blood (2017) 130 (Supplement 1): 3244.

https://doi.org/10.1182/blood.V130.Suppl_1.3244.3244

Published: 2017

Journal Articles

High Progression-Free Survival after Reduced Intensity Total Body Irradiation-Based Conditioning in Patients Allografted for Chronic Myelomonocytic Leukemia (CMML)

Aleksandar Radujkovic, MD, Ute Hegenbart, Carsten Müller-Tidow, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2017) 130 (Supplement 1): 4571.

https://doi.org/10.1182/blood.V130.Suppl_1.4571.4571

Published: 2017

Journal Articles

Low Pre-Transplant Testosterone Levels in Male Patients Are Associated with Endothelial Vulnerability and Non-Relapse Mortality after Allogeneic Stem Cell Transplantation

Aleksandar Radujkovic, MD, Dietrich W. Beelen, Prof. Dr. MD, Christian Kasperk, Anthony D. Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2016) 128 (22): 4587.

https://doi.org/10.1182/blood.V128.22.4587.4587

Published: 2016

Journal Articles

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Thomas Luft, MD PhD, Axel Benner, Sonata Jodele, MD, Christopher E. Dandoy, MD, Rainer F. Storb, MD, Ted A. Gooley, PhD, Brenda M. Sandmaier, MD, Aleksandar Radujkovic, MD, Anthony D. Ho, MD, Peter Dreger, MD, Olaf Penack, MD

Blood (2016) 128 (22): 519.

https://doi.org/10.1182/blood.V128.22.519.519

Published: 2016

Journal Articles

ATG and Statins Reduce Incidence of Severe Chronic Gvhd By Distinct Mechanisms Involving CXCL9 and Kynurenine Catabolism

Thomas Luft, MD PhD, Katharina Schmidt, MD, Karl-Heinz Kellner, PhD, Aleksandar Radujkovic, MD, Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Ute Hegenbart, MD, Anthony D. Ho, MD, Peter Dreger, MD

Blood (2015) 126 (23): 856.

https://doi.org/10.1182/blood.V126.23.856.856

Published: 2015

Journal Articles

Low Vitamin D Levels Are Associated with Inferior Survival Following Azacitidine Treatment in Patients with Myelodysplastic Syndrome

Aleksandar Radujkovic, MD, Paul Schnitzler, MD, Anthony D. Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2015) 126 (23): 1699.

https://doi.org/10.1182/blood.V126.23.1699.1699

Published: 2015

Journal Articles

Cytokeratin (CK)-18 and CK18 Fragments As Sensitive and Specific Biomarkers of Acute Hepato-Intestinal Gvhd: Results of a Prospective Observational Study

Sandra Sauer, MD, Aleksandar Radujkovic, MD, Ute Hegenbart, MD, Anthony D Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2015) 126 (23): 3083.

https://doi.org/10.1182/blood.V126.23.3083.3083

Published: 2015

Journal Articles

Pre-Transplant Weight Loss Influences Outcome of Patients with Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Aleksandar Radujkovic, MD, Natalia Becker, Axel Benner, Sascha Dietrich, MD, Olaf Penack, Uwe Platzbecker, MD, Friedrich Stölzel, MD, Martin Bornhäuser, MD, Ute Hegenbart, MD, Anthony D Ho, MD, Peter Dreger, MD, Thomas Luft

Blood (2014) 124 (21): 3950.

https://doi.org/10.1182/blood.V124.21.3950.3950

Published: 2014

Journal Articles

Female Donors Are Associated with an Increased Risk of Chronic Graft-Versus-Host Disease (cGVHD) Independent of Recipient Sex but Provide Superior Graft-Versus-Leukemia Activity Once cGVHD Is Established

Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Katharina Schmidt, MD, Joe Puthenparambil, MD, Aleksandar Radujkovic, MD, Sascha Dietrich, MD, Anthony D Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 3917.

https://doi.org/10.1182/blood.V124.21.3917.3917

Published: 2014

NARROW

Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation

Easix for Prediction of Survival in Myelodysplastic Syndromes

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

High Pre-Transplant Free Interleukin-18 Is Associated with Poor Hematopoietic Recovery after Allogeneic Stem Cell Transplantation

Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT

The CXCL9 Polymorphism rs884304 Associates with Early CXCL9 Reconstitution and with Severe Chronic Graft-Versus-Host Disease (cGVHD) in Human Allograft Recipients

Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors — a Retrospective Study By the EBMT Chronic Malignancies Working Party

Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins

High Progression-Free Survival after Reduced Intensity Total Body Irradiation-Based Conditioning in Patients Allografted for Chronic Myelomonocytic Leukemia (CMML)

Low Pre-Transplant Testosterone Levels in Male Patients Are Associated with Endothelial Vulnerability and Non-Relapse Mortality after Allogeneic Stem Cell Transplantation

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

ATG and Statins Reduce Incidence of Severe Chronic Gvhd By Distinct Mechanisms Involving CXCL9 and Kynurenine Catabolism

Low Vitamin D Levels Are Associated with Inferior Survival Following Azacitidine Treatment in Patients with Myelodysplastic Syndrome

Cytokeratin (CK)-18 and CK18 Fragments As Sensitive and Specific Biomarkers of Acute Hepato-Intestinal Gvhd: Results of a Prospective Observational Study

Pre-Transplant Weight Loss Influences Outcome of Patients with Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Female Donors Are Associated with an Increased Risk of Chronic Graft-Versus-Host Disease (cGVHD) Independent of Recipient Sex but Provide Superior Graft-Versus-Leukemia Activity Once cGVHD Is Established

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only